In response to the Seattle City Council’s request for policy advice on how to curb overdose deaths, a local task force is recommending the widespread decriminalization of all drugs.

Red Light Holland reports its Q1 for fiscal year 2022. The company also confirms closing on its acquisition of Mera Life Sciences.

A U.S. military veteran who was deported to Jamaica over a marijuana conviction has been allowed to return to the country following a concerted push for relief by members of Congress.

As Democrats in Congress appear eager to finally tackle comprehensive marijuana reform, Colorado Governor Jared Polis hopes they address one particular cannabis policy first. ​​​​​​​

After our July interview with CEO Kelsey Ramsden about the company’s Ibogaine synthesis, August brought more exciting announcements for Mind Cure Health Inc.

As investors look to fine-tune their portfolios after the summer, we review the psychedelic drug industry and public company performance in 2021.

Former New Orleans Saints player Steve Gleason said Friday that medical marijuana saved him from a “downward spiral” after his ALS diagnosis.

Advocates in Missouri have filed a ballot initiative to legalize cannabis for adults in the state and now must collect 175,000 signatures to put the issue to voters during next year’s midterm elections.

MINDCURE has released the initial version of its iSTRYM digital therapeutics platform and expects to begin full commercial deployment in Q1 of 2022.

The U.S. Department of Agriculture is moving forward with a large-scale survey to gain insight into the hemp market that’s emerged since the crop was federally legalized under the 2018 Farm Bill.